|
Volumn 13, Issue 4, 2003, Pages 657-660
|
Design, synthesis and biological evaluation of benzimidazole/benzothiazole and benzoxazole derivatives as cyclooxygenase inhibitors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [[(2 METHOXY 6 PENTADECYLPHENYL)METHYL]THIO]BENZOTHIAZOLE;
5 (METHOXY) 2 [[(2 HYDROXY 6 PENTADECYLPHENYL)METHYL]THIO] 1H BENZIMIDAZOLE;
ANACARDIC ACID;
BENZIMIDAZOLE DERIVATIVE;
BENZOTHIAZOLE DERIVATIVE;
BENZOXAZOLE DERIVATIVE;
CYCLOOXYGENASE 1 INHIBITOR;
CYCLOOXYGENASE 2 INHIBITOR;
PROSTAGLANDIN SYNTHASE INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
DRUG DESIGN;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN;
IC 50;
INFRARED SPECTROSCOPY;
MASS SPECTROMETRY;
PROTON NUCLEAR MAGNETIC RESONANCE;
BENZIMIDAZOLES;
BENZOTHIAZOLES;
BENZOXAZOLES;
BLOOD;
CYCLOOXYGENASE 1;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DRUG EVALUATION, PRECLINICAL;
HETEROCYCLIC COMPOUNDS;
HUMANS;
INHIBITORY CONCENTRATION 50;
ISOENZYMES;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
STRUCTURE-ACTIVITY RELATIONSHIP;
THIAZOLES;
|
EID: 0037294820
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)01006-5 Document Type: Article |
Times cited : (289)
|
References (25)
|